Symmetry Medical Inc.’s (SMA) share price has entered into oversold territory with a stochastic value of 5.995. The Zacks Consensus Estimate on the company’s earnings for year ending December 2012 increased by 2 cents over the past month to 52 cents per share. Symmetry Medical is a Zacks #2 Rank (“Buy”) company.
SYMMETRY MEDICL (SMA): Free Stock Analysis Report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment